Search for other papers by P. L. Latchman in
Current site
Google Scholar
PubMed
Search for other papers by G. Gates in
Current site
Google Scholar
PubMed
Search for other papers by J. Pereira in
Current site
Google Scholar
PubMed
Search for other papers by R. Axtell R in
Current site
Google Scholar
PubMed
Search for other papers by K. Gardner in
Current site
Google Scholar
PubMed
Search for other papers by J. Schlie in
Current site
Google Scholar
PubMed
Search for other papers by Q. Yang in
Current site
Google Scholar
PubMed
Search for other papers by T. Yue in
Current site
Google Scholar
PubMed
Search for other papers by A. Morin-Viall in
Current site
Google Scholar
PubMed
Search for other papers by R. DeMeersman in
Current site
Google Scholar
PubMed
Abstract
Purpose
High central blood pressure is more predictive of cardiovascular disease (CVD) versus high peripheral blood pressure. Measures of central pressures (CPs) include, central systolic blood pressure (CSBP) and central diastolic blood pressure. Measures of central pressures augmentation (CPsA) include augmentation pressure (AP) and the augmentation index @ 75 beats·min−1 (AIx@75). Increased sympathetic tone (ST) is also associated with CVD. The low to high frequency ratio (LF/HF) is often used to determine sympatho-vagal balance. Given the association between ST, CPs, CPsA and CVD there is a need to understand the association between these predictors of CVD. The aims of this study were to examine the association between the LF/HF ratio, CPs, and CPsA in men and women collectively and based on gender.
Methods
We measured the LF/HF ratio, CSBP, AP, and AIx@75 in 102 participants (41F/61M). The LF/HF ratio was determined via power spectral density analysis. CSBP, AP, and AIx@75 were determined via applanation tonometry.
Results
The LF/HF ratio was inversely associated with AP (r = –0.26) and AIx @75 (r = –0.29) in the combined group of men and women. The LF/HF ratio was inversely associated with CSBP (r = –0.27), AP (r = –0.28), and AIx@75 (r = –0.32) in men, but not in women.
Conclusion
There is an inverse association between the LF/HF ratio, AP, and AIx@75 in men and women combined. The association between the LF/HF ratio, CSBP, AP, and AIx@75, differs based on gender.
-
[1]
Bauer P, Kraushaar L, Hölscher S, Tajmiri-Gondai S, Dörr O, Nef H, et al.. Most A: Elite athletes as research model: vitamin D insufficiency associates with elevated central blood pressure in professional handball athletes. Eur J Appl Physiol 2019; 119: 2265–2274.
-
[2]
Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al.. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014; 63: 636–646.
-
[3]
Billman GE. The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front Physiol 2013; 4: 26.
-
[4]
Casey DP, Curry TP, Joyner MJ, Charkoudian N, Hart EC. Relationship between muscle sympathetic nerve activity and aortic wave reflection characteristics in young men and women. Hypertension 2011; 57: 421–427.
-
[5]
Celik G, Yilmaz S, Kebapcilar L, Gundogdu A. Central arterial characteristics of gout patients with chronic kidney diseases. Int J Rheum Dis 2017; 20: 628–638.
-
[6]
Charkoudian N, Joyner MJ, Johnson CP, Eisenach JH, Dietz NM, Wallin BG. Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation. J Physiol 2005; 568: 315–321.
-
[7]
Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, et al.. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997; 95: 1827–1836.
-
[8]
Chirinos JA, Zambrando JP, Chakko S, Veerani A, Schob A, Willens HJ, et al.. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 2005; 45: 980–985.
-
[9]
Demeersman R, Reisman S, Daum M, Zorowitz R, Findley T. Influence of respiration on metabolic, hemodynamic, psychometric, and R-R interval spectral parameters. Am J Physiol Heart Circ Physiol 1995; 269: 1437–1544.
-
[10]
Grassi G, Seravalle G, Mancia G. Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications. Eur J Clin Invest 2015; 45: 1367–1375.
-
[11]
Hart EC, Charkoudian N, Wallin BG, Curry TB, Eisenach JH, Joyner MJ. Sex differences in sympathetic neural-hemodynamic balance: implication for human blood pressure regulation. Hypertension 2009; 53: 571–576.
-
[12]
Hashimoto J, Ito S. Central blood pressure and predictors of cardiovascular events. Curr Hypertens Rev 2012; 8: 108–113.
-
[13]
Hayashi T, Nakayama Y, Tsumura K, Yoshimaru K, Ueda H. Reflection in the arterial system and the risk of coronary heart disease. Am J Hypertens 2002; 15: 405–409.
-
[14]
Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043–1065.
-
[15]
Hoogerwaard AF, de Jong MR, Adiyaman A, Smit JJJ, Delnoy PPHM, Heeg JE, et al.. Renal sympathetic denervation induces changes in heart rate variability and is associated with a lower sympathetic tone. Clin Res Cardiol 2019; 108: 22–30.
-
[16]
Imanishi R, Seto S, Toda G, Yoshida M, Ohtsuru A, Koide Y, et al.. High Brachial-Ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res 2004; 27: 71–78.
-
[17]
Phoemsapthawee J, Prasertsri P, Leelayuwat N. Heart rate variability responses to a combined exercise training program: correlation with adiposity and cardiorespiratory fitness changes in obese young men. J Exerc Rehabil 2019; 15(1): 114–122.
-
[18]
Joyner MJ, Charkoudian N, Wallin BG. Sympathetic nervous system and blood pressure in humans: individualized patterns of regulation and their implications. Hypertension 2010; 56(1): 10–16.
-
[19]
Latchman PL, Thiel R, Gates G, Zhu W, Axtell R, Gardner K, et al.. A predictor of heart rate adjusted augmentation index in men but not in women. Open J Mol Integr Physiol 2017; 7: 41–51.
-
[20]
London GM, Blacher J, Pannier B, Guerin AP, Marchias SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38: 434–438.
-
[21]
Manolis AJ, Poulimenos LE, Kallistratos MS, Gavras I, Gavras H. Sympathetic overactivity in hypertension and cardiovascular disease. Curr Vasc Pharmacol 2014; 12: 4–15.
-
[22]
Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 2008; 60(2): 210–241.
-
[23]
Ohta M, Ueda T, Sakurai K. Changes in autonomic nervous activity during ingestion of soft food in older nursing home residents. Bull Tokyo Dent Coll 2018; 59: 257–263.
-
[24]
O'Rourke MF, Pauca AL, Jiang X. Pulse wave analysis. Br J Clin Pharmacol 2001; 51: 507–522.
-
[25]
Pagani M, Lambardi F, Guzzetti S, Rimoldi O, Furlan R, Pinzinelli P, et al.. Power spectral analysis of heart rate and arterial pressure variabilities as markers of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178–193.
-
[26]
Pagani M, Lambardi F, Guzetti S, Sandrone G, Rimoldi O, Malfatto G, et al.. Power spectral density of heart rate variability as an index of sympatho-vagal interaction in normal and hypertensive subjects. J Hypertens Suppl 1984; 2: 383–385.
-
[27]
Panday KR, Panday DP. Heart rate variability. J Clin Exp Cardiol 2018; 9: 1–12.
-
[28]
Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38: 932–937.
-
[29]
Pini R, Cavallini MC, Palmieri V, Marchionni N, Di Bari M, Devereux RB, et al.. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the icare dicomano study. J Am Coll Cardiol 2008; 51: 2432–2439.
-
[30]
Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shad AD, Denaxas S, et al.. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet 2014; 383: 1899–1911.
-
[31]
Roman MJ, Devereux RB, Kizer JR, Lee ET, Gallowway JM, Ali T, et al.. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the strong heart study. Hypertension 2007; 50: 197–203.
-
[32]
Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al.. Global, regional, and national burden of cardiovascular disease for 10 Causes, 1990 to 2015. J Am Coll Cardiol 2017; 70: 1–25.
-
[33]
Smulyan H, Marchais SJ, Pannier B, Guerin AP, Safar ME, London GM. Influence of body height on pulsatile arterial hemodynamic data. J Am Coll Cardiol 1998; 31(5): 1103–1109.
-
[34]
Tessier MP, Pennestri MH, Godbout R. Heart rate variability of typically developing and autistic children and adults before, during and after sleep. Int J Phsycophysiol 2018; 134: 15–21.
-
[35]
Wang KL, Cheng HM, Chuang SY, Spurgeon HA, Ting CT, Lakatta EG, et al.. Central or peripheral systolic or pulse pressure: which best to target organs and future mortality? J Hypertens 2009; 27: 461–467.
-
[36]
Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, et al.. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109: 184–189.
-
[37]
Wilkinson I, Maccallum H, Flint L, Cockcroft J, Newby D, Webb D. The influence of heart rate on augmentation index and central pressure in humans. J Physiol 2000; 525: 263–270.
-
[38]
Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al.. CAFÉ investigators; Anglo-Scandinavian cardiac outcomes trial investigators; CAFÉ steering committee and writing committee: differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study. Circulation 2006; 113: 1213–1225.
-
[39]
Zhang DY, Anderson AS. The sympathetic nervous system and heart failure. Cardiol Clin 2014; 32: 33–45.
-
[40]
Zhao Y, Vanhoutte PM, Leung SWS. Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci 2015; 129: 83–94.
Editor-in-Chief
László ROSIVALL (Semmelweis University, Budapest, Hungary)
Managing Editor
Anna BERHIDI (Semmelweis University, Budapest, Hungary)
Co-Editors
- Gábor SZÉNÁSI (Semmelweis University, Budapest, Hungary)
- Ákos KOLLER (Semmelweis University, Budapest, Hungary)
- Zsolt RADÁK (University of Physical Education, Budapest, Hungary)
- László LÉNÁRD (University of Pécs, Hungary)
- Zoltán UNGVÁRI (Semmelweis University, Budapest, Hungary)
Assistant Editors
- Gabriella DÖRNYEI (Semmelweis University, Budapest, Hungary)
- Zsuzsanna MIKLÓS (Semmelweis University, Budapest, Hungary)
- György NÁDASY (Semmelweis University, Budapest, Hungary)
Hungarian Editorial Board
- György BENEDEK (University of Szeged, Hungary)
- Zoltán BENYÓ (Semmelweis University, Budapest, Hungary)
- Mihály BOROS (University of Szeged, Hungary)
- László CSERNOCH (University of Debrecen, Hungary)
- Magdolna DANK (Semmelweis University, Budapest, Hungary)
- László DÉTÁRI (Eötvös Loránd University, Budapest, Hungary)
- Zoltán GIRICZ (Semmelweis University, Budapest, Hungary and Pharmahungary Group, Szeged, Hungary)
- Zoltán HANTOS (Semmelweis University, Budapest and University of Szeged, Hungary)
- Zoltán HEROLD (Semmelweis University, Budapest, Hungary)
- László HUNYADI (Semmelweis University, Budapest, Hungary)
- Gábor JANCSÓ (University of Pécs, Hungary)
- Zoltán KARÁDI (University of Pecs, Hungary)
- Miklós PALKOVITS (Semmelweis University, Budapest, Hungary)
- Gyula PAPP (University of Szeged, Hungary)
- Gábor PAVLIK (University of Physical Education, Budapest, Hungary)
- András SPÄT (Semmelweis University, Budapest, Hungary)
- Gyula SZABÓ (University of Szeged, Hungary)
- Zoltán SZELÉNYI (University of Pécs, Hungary)
- Lajos SZOLLÁR (Semmelweis University, Budapest, Hungary)
- József TOLDI (MTA-SZTE Neuroscience Research Group and University of Szeged, Hungary)
- Árpád TÓSAKI (University of Debrecen, Hungary)
International Editorial Board
- Dragan DJURIC (University of Belgrade, Serbia)
- Christopher H. FRY (University of Bristol, UK)
- Stephen E. GREENWALD (Blizard Institute, Barts and Queen Mary University of London, UK)
- Tibor HORTOBÁGYI (University of Groningen, Netherlands)
- George KUNOS (National Institutes of Health, Bethesda, USA)
- Massoud MAHMOUDIAN (Iran University of Medical Sciences, Tehran, Iran)
- Tadaaki MANO (Gifu University of Medical Science, Japan)
- Luis Gabriel NAVAR (Tulane University School of Medicine, New Orleans, USA)
- Hitoo NISHINO (Nagoya City University, Japan)
- Ole H. PETERSEN (Cardiff University, UK)
- Ulrich POHL (German Centre for Cardiovascular Research and Ludwig-Maximilians-University, Planegg, Germany)
- Andrej A. ROMANOVSKY (University of Arizona, USA)
- Anwar Ali SIDDIQUI (Aga Khan University, Karachi, Pakistan)
- Csaba SZABÓ (University of Fribourg, Switzerland)
- Eric VICAUT (Université de Paris, UMRS 942 INSERM, France)
Editorial Correspondence:
Physiology International
Semmelweis University
Faculty of Medicine, Institute of Translational Medicine
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: pi@semmelweis.hu
Indexing and Abstracting Services:
- Biological Abstracts
- BIOSIS Previews
- CAB Abstracts
- CABELLS Journalytics
- EMBASE/Excerpta Medica
- Global Health
- Index Copernicus
- Index Medicus
- Medline
- Referativnyi Zhurnal
- SCOPUS
- WoS - Science Citation Index Expanded
| 2023 | |
|---|---|
| Web of Science | |
| Journal Impact Factor | 2.2 |
| Rank by Impact Factor | Q3 (Physiology) |
| Journal Citation Indicator | 0.58 |
| Scopus | |
| CiteScore | 3.4 |
| CiteScore rank | Q2 (Physical Therapy, Sports Therapy and Rehabilitation) |
| SNIP | 0.508 |
| Scimago | |
| SJR index | 0.407 |
| SJR Q rank | Q2 |
| Physiology International | |
|---|---|
| Publication Model | Hybrid |
| Submission Fee | none |
| Article Processing Charge | 1100 EUR/article |
| Printed Color Illustrations | 40 EUR (or 10 000 HUF) + VAT / piece |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription fee 2025 | Online subsscription: 752 EUR / 828 USD Print + online subscription: 880 EUR / 968 USD |
| Subscription Information | Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content. |
| Purchase per Title | Individual articles are sold on the displayed price. |
| Physiology International | |
|---|---|
| Language | English |
| Size | B5 |
| Year of Foundation |
2006 (1950) |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Magyar Tudományos Akadémia |
| Founder's Address |
H-1051 Budapest, Hungary, Széchenyi István tér 9. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 2498-602X (Print) |
| ISSN | 2677-0164 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Aug 2024 | 62 | 1 | 1 |
| Sep 2024 | 86 | 0 | 0 |
| Oct 2024 | 223 | 0 | 0 |
| Nov 2024 | 84 | 0 | 0 |
| Dec 2024 | 88 | 0 | 0 |
| Jan 2025 | 38 | 0 | 0 |
| Feb 2025 | 0 | 0 | 0 |
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.